{"id":15023,"date":"2025-01-28T11:19:04","date_gmt":"2025-01-28T11:19:04","guid":{"rendered":"https:\/\/genekor.com\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/"},"modified":"2025-02-11T13:11:38","modified_gmt":"2025-02-11T13:11:38","slug":"tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer","status":"publish","type":"post","link":"https:\/\/genekor.com\/ro\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/","title":{"rendered":"Teste de profil tumoral pentru ghidarea deciziilor privind chimioterapia adjuvant\u0103 \u00een cancerul de s\u00e2n incipient"},"content":{"rendered":"\n<p><\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-ghid-de-diagnosticare-nice-evaluarea-eficacita\u021bii-\u0219i-eficien\u021bei\"><strong><strong>Ghid de diagnosticare NICE \u2013 evaluarea eficacit\u0103\u021bii \u0219i eficien\u021bei<\/strong><\/strong><\/h3>\n\n\n\n<p><strong><br><\/strong>Ghidul de diagnosticare NICE (<em>Institutul Na\u021bional pentru S\u0103n\u0103tate \u0219i Excelen\u021b\u0103 \u00een \u00cengrijire<\/em>) DG58 ofer\u0103 <strong>recomand\u0103ri bazate pe dovezi pentru a ghida deciziile de tratament<\/strong> \u0219i a evalua <strong>eficien\u021ba \u0219i raportul cost-eficien\u021b\u0103<\/strong> al produselor \u0219i serviciilor \u00een sistemul de s\u0103n\u0103tate din Anglia \u0219i \u021aara Galilor.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<p><\/p>\n\n\n\n<p><strong>Utilizarea testelor multigenice (MGAs) pentru profilul tumorilor<\/strong><br>Profilul tumoral prin MGAs poate ajuta \u00een luarea deciziilor \u00een ceea ce prive\u0219te chimioterapia adjuvant\u0103, identific\u00e2nd pacien\u021bii care:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>\u00a0<\/strong>Ar putea<strong> s\u0103 nu aib\u0103 beneficii<\/strong> <strong>de la tratamentul cu chimioterapie adjuvant\u0103<\/strong>, permi\u021b\u00e2ndu-le <strong>s\u0103 evite tratamentele inutile<\/strong>.<\/li>\n\n\n\n<li>Ar <strong>avea<\/strong> <strong>beneficii de la tratamentul cu chimioterapie<\/strong>, de\u0219i prezint\u0103 un<strong> risc<\/strong> <strong>sc\u0103zut <\/strong>de recuren\u021b\u0103 a bolii <strong>pe baza factorilor clinici<\/strong>.<\/li>\n<\/ul>\n\n\n\n<p><strong>Cum determin\u0103 NICE raportul cost-eficien\u021b\u0103<\/strong><br>Analiza cost-eficien\u021b\u0103 este realizat\u0103 pe baza determin\u0103rii <strong>raportului incremental cost-eficien\u021b\u0103<\/strong> (ICER). Acesta se calculeaz\u0103 \u00eemp\u0103r\u021bind diferen\u021ba de cost la diferen\u021ba de <strong>ani de via\u021b\u0103 ajusta\u021bi \u00een func\u021bie de calitate<\/strong> (QALY) pentru testele multigenice (MGA), comparativ cu profilarea tumorilor clinic\u0103\/patologic\u0103.<\/p>\n\n\n\n<p><strong>ICER<\/strong> = <em><u>diferen\u021b\u0103 de cost<\/u><\/em> &nbsp;&nbsp;&nbsp;&nbsp;=&nbsp;&nbsp;&nbsp;&nbsp; costuri <em><u>MGA<\/u><\/em> \u2013 costuri <em><u>ClinPath<\/u><\/em><\/p>\n\n\n\n<p><em>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; diferen\u021b\u0103 QALY<\/em>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; QALY <em>MGA <\/em>\u2013QALY <em>ClinPath<\/em><\/p>\n\n\n\n<p>Un <strong>ICER &lt; 20.000 \u00a3<\/strong> per QALY c\u00e2\u0219tigat este considerat a fi <strong>cost-eficient<\/strong> de c\u0103tre Serviciul Na\u021bional de S\u0103n\u0103tate (NHS).<\/p>\n\n\n\n<p>Acest rezumat al ghidului de diagnostic NICE \u201eTestele de profil tumoral pentru ghidarea deciziilor privind chimioterapia adjuvant\u0103 \u00een cancerul de s\u00e2n \u00een stadiu incipient\u201d (DG58) este un material promo\u021bional.<br>NICE a verificat acurate\u021bea con\u021binutului acestui pliant referitor \u00een mod specific la ghidul NICE. NICE este independent de orice companie sau produs promovat.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-valoarea-economica-a-testelor-multigenice-mgas\"><strong>Valoarea economic\u0103 a testelor multigenice (MGAs)<\/strong><\/h2>\n\n\n\n<p><br>Modelarea economic\u0103 sugereaz\u0103 c\u0103 <strong>Oncotype DX<\/strong>\u00ae, EndoPredict\u00ae \u0219i Prosigna\u00ae sunt <strong>eficiente din punct de vedere al costurilor<\/strong> \u00een compara\u021bie cu \u00eengrijirea standard la femeile aflate la menopauz\u0103. Toate cele 3 teste au avut <strong>ICER-uri &lt; \u00a3 20.000 per QALY<\/strong> c\u00e2\u0219tigat \u00een compara\u021bie cu situa\u021bia \u00een care nu s-ar utiliza teste de profil tumoral.<\/p>\n\n\n\n<p>MammaPrint\u00ae este probabil mai pu\u021bin eficient din punct de vedere clinic \u0219i mai costisitor dec\u00e2t \u00eengrijirea standard.<\/p>\n\n\n\n<p><strong>Raportul cost-eficien\u021b\u0103 pentru Oncotype DX\u00ae<\/strong><br><br>3.18<br>Comisia a concluzionat c\u0103 Oncotype DX\u00ae are probabil o utilizare eficient\u0103 din punct de vedere al costurilor, pentru resursele NHS atunci c\u00e2nd este folosit pentru a ghida deciziile legate de chimioterapia adjuvant\u0103 la femeile aflate la menopauz\u0103.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-impactul-asupra-serviciilor-de-chimoterapie\"><strong>Impactul asupra serviciilor de chimoterapie<\/strong><\/h3>\n\n\n\n<p><\/p>\n\n\n\n<p>3.21<br>EndoPredict\u00ae, <strong>Oncotype DX\u00ae<\/strong> \u0219i Prosigna\u00ae sunt toate mai probabil de a fi eficiente din punct de vedere al costurilor comparativ cu situa\u021bia \u00een care nu se utilizeaz\u0103 teste de profil tumoral.<\/p>\n\n\n\n<p>3.21<br>Modelul economic al EAG a prezis c\u0103 prin efectuarea analizei <strong>Oncotype DX\u00ae,<\/strong> <strong>cu 594 mai pu\u021binefemei vor fi supuse chimioterapiei din 1.000 testate<\/strong>, \u00een timp ce cu EndoPredict\u00ae sau Prosigna\u00ae reducerea a fost \u00een jur de 40.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td>ICER = raport cost-eficien\u021b\u0103 incremental<br> QALY = durat\u0103 de caliatate ajustat\u0103 <br>EAC = grup de evaluare extern<\/td><td><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ghid de diagnosticare NICE \u2013 evaluarea eficacit\u0103\u021bii \u0219i eficien\u021bei Ghidul de diagnosticare NICE (Institutul Na\u021bional pentru S\u0103n\u0103tate \u0219i Excelen\u021b\u0103 \u00een \u00cengrijire) DG58 ofer\u0103 recomand\u0103ri bazate pe dovezi pentru a ghida [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":15021,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[92],"tags":[],"class_list":["post-15023","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-ro"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.0 (Yoast SEO v24.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Teste de profil tumoral pentru ghidarea deciziilor privind chimioterapia adjuvant\u0103 \u00een cancerul de s\u00e2n incipient - Genekor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/genekor.com\/ro\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"ro_RO\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Teste de profil tumoral pentru ghidarea deciziilor privind chimioterapia adjuvant\u0103 \u00een cancerul de s\u00e2n incipient\" \/>\n<meta property=\"og:description\" content=\"Ghid de diagnosticare NICE \u2013 evaluarea eficacit\u0103\u021bii \u0219i eficien\u021bei Ghidul de diagnosticare NICE (Institutul Na\u021bional pentru S\u0103n\u0103tate \u0219i Excelen\u021b\u0103 \u00een \u00cengrijire) DG58 ofer\u0103 recomand\u0103ri bazate pe dovezi pentru a ghida [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/genekor.com\/ro\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"Genekor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/genekorbiotechnology\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-28T11:19:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-11T13:11:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/genekor.com\/wp-content\/uploads\/2025\/01\/logo-landscape-800x281-800x281-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"281\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Ioanna Potska\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Scris de\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ioanna Potska\" \/>\n\t<meta name=\"twitter:label2\" content=\"Timp estimat pentru citire\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/genekor.com\/ro\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/genekor.com\/ro\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/\"},\"author\":{\"name\":\"Ioanna Potska\",\"@id\":\"https:\/\/genekor.com\/ro\/#\/schema\/person\/d6c43cd4b4be66582d408967392cbcbd\"},\"headline\":\"Teste de profil tumoral pentru ghidarea deciziilor privind chimioterapia adjuvant\u0103 \u00een cancerul de s\u00e2n incipient\",\"datePublished\":\"2025-01-28T11:19:04+00:00\",\"dateModified\":\"2025-02-11T13:11:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/genekor.com\/ro\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/\"},\"wordCount\":528,\"publisher\":{\"@id\":\"https:\/\/genekor.com\/ro\/#organization\"},\"image\":{\"@id\":\"https:\/\/genekor.com\/ro\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/genekor.com\/wp-content\/uploads\/2025\/01\/logo-landscape-800x281-800x281-1.png\",\"articleSection\":[\"news\"],\"inLanguage\":\"ro-RO\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/genekor.com\/ro\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/\",\"url\":\"https:\/\/genekor.com\/ro\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/\",\"name\":\"Teste de profil tumoral pentru ghidarea deciziilor privind chimioterapia adjuvant\u0103 \u00een cancerul de s\u00e2n incipient - Genekor\",\"isPartOf\":{\"@id\":\"https:\/\/genekor.com\/ro\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/genekor.com\/ro\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/genekor.com\/ro\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/genekor.com\/wp-content\/uploads\/2025\/01\/logo-landscape-800x281-800x281-1.png\",\"datePublished\":\"2025-01-28T11:19:04+00:00\",\"dateModified\":\"2025-02-11T13:11:38+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/genekor.com\/ro\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/#breadcrumb\"},\"inLanguage\":\"ro-RO\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/genekor.com\/ro\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ro-RO\",\"@id\":\"https:\/\/genekor.com\/ro\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/#primaryimage\",\"url\":\"https:\/\/genekor.com\/wp-content\/uploads\/2025\/01\/logo-landscape-800x281-800x281-1.png\",\"contentUrl\":\"https:\/\/genekor.com\/wp-content\/uploads\/2025\/01\/logo-landscape-800x281-800x281-1.png\",\"width\":800,\"height\":281},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/genekor.com\/ro\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/genekor.com\/ro\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Teste de profil tumoral pentru ghidarea deciziilor privind chimioterapia adjuvant\u0103 \u00een cancerul de s\u00e2n incipient\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/genekor.com\/ro\/#website\",\"url\":\"https:\/\/genekor.com\/ro\/\",\"name\":\"Genekor\",\"description\":\"Medicina personalizat\u0103\",\"publisher\":{\"@id\":\"https:\/\/genekor.com\/ro\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/genekor.com\/ro\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ro-RO\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/genekor.com\/ro\/#organization\",\"name\":\"Genekor\",\"url\":\"https:\/\/genekor.com\/ro\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ro-RO\",\"@id\":\"https:\/\/genekor.com\/ro\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/genekor.com\/wp-content\/uploads\/2021\/09\/logo-black.svg\",\"contentUrl\":\"https:\/\/genekor.com\/wp-content\/uploads\/2021\/09\/logo-black.svg\",\"width\":1,\"height\":1,\"caption\":\"Genekor\"},\"image\":{\"@id\":\"https:\/\/genekor.com\/ro\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/genekorbiotechnology\/\",\"https:\/\/gr.linkedin.com\/company\/genekor-sa\",\"https:\/\/www.youtube.com\/channel\/UCKC7sMFecVBY-OZAlRBHNzA\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/genekor.com\/ro\/#\/schema\/person\/d6c43cd4b4be66582d408967392cbcbd\",\"name\":\"Ioanna Potska\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ro-RO\",\"@id\":\"https:\/\/genekor.com\/ro\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ef44ac80c13d1335f0ea78257146bbf1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ef44ac80c13d1335f0ea78257146bbf1?s=96&d=mm&r=g\",\"caption\":\"Ioanna Potska\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Teste de profil tumoral pentru ghidarea deciziilor privind chimioterapia adjuvant\u0103 \u00een cancerul de s\u00e2n incipient - Genekor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/genekor.com\/ro\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/","og_locale":"ro_RO","og_type":"article","og_title":"Teste de profil tumoral pentru ghidarea deciziilor privind chimioterapia adjuvant\u0103 \u00een cancerul de s\u00e2n incipient","og_description":"Ghid de diagnosticare NICE \u2013 evaluarea eficacit\u0103\u021bii \u0219i eficien\u021bei Ghidul de diagnosticare NICE (Institutul Na\u021bional pentru S\u0103n\u0103tate \u0219i Excelen\u021b\u0103 \u00een \u00cengrijire) DG58 ofer\u0103 recomand\u0103ri bazate pe dovezi pentru a ghida [&hellip;]","og_url":"https:\/\/genekor.com\/ro\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/","og_site_name":"Genekor","article_publisher":"https:\/\/www.facebook.com\/genekorbiotechnology\/","article_published_time":"2025-01-28T11:19:04+00:00","article_modified_time":"2025-02-11T13:11:38+00:00","og_image":[{"width":800,"height":281,"url":"https:\/\/genekor.com\/wp-content\/uploads\/2025\/01\/logo-landscape-800x281-800x281-1.png","type":"image\/png"}],"author":"Ioanna Potska","twitter_card":"summary_large_image","twitter_misc":{"Scris de":"Ioanna Potska","Timp estimat pentru citire":"2 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/genekor.com\/ro\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/#article","isPartOf":{"@id":"https:\/\/genekor.com\/ro\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/"},"author":{"name":"Ioanna Potska","@id":"https:\/\/genekor.com\/ro\/#\/schema\/person\/d6c43cd4b4be66582d408967392cbcbd"},"headline":"Teste de profil tumoral pentru ghidarea deciziilor privind chimioterapia adjuvant\u0103 \u00een cancerul de s\u00e2n incipient","datePublished":"2025-01-28T11:19:04+00:00","dateModified":"2025-02-11T13:11:38+00:00","mainEntityOfPage":{"@id":"https:\/\/genekor.com\/ro\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/"},"wordCount":528,"publisher":{"@id":"https:\/\/genekor.com\/ro\/#organization"},"image":{"@id":"https:\/\/genekor.com\/ro\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/genekor.com\/wp-content\/uploads\/2025\/01\/logo-landscape-800x281-800x281-1.png","articleSection":["news"],"inLanguage":"ro-RO"},{"@type":"WebPage","@id":"https:\/\/genekor.com\/ro\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/","url":"https:\/\/genekor.com\/ro\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/","name":"Teste de profil tumoral pentru ghidarea deciziilor privind chimioterapia adjuvant\u0103 \u00een cancerul de s\u00e2n incipient - Genekor","isPartOf":{"@id":"https:\/\/genekor.com\/ro\/#website"},"primaryImageOfPage":{"@id":"https:\/\/genekor.com\/ro\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/#primaryimage"},"image":{"@id":"https:\/\/genekor.com\/ro\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/genekor.com\/wp-content\/uploads\/2025\/01\/logo-landscape-800x281-800x281-1.png","datePublished":"2025-01-28T11:19:04+00:00","dateModified":"2025-02-11T13:11:38+00:00","breadcrumb":{"@id":"https:\/\/genekor.com\/ro\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/#breadcrumb"},"inLanguage":"ro-RO","potentialAction":[{"@type":"ReadAction","target":["https:\/\/genekor.com\/ro\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/"]}]},{"@type":"ImageObject","inLanguage":"ro-RO","@id":"https:\/\/genekor.com\/ro\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/#primaryimage","url":"https:\/\/genekor.com\/wp-content\/uploads\/2025\/01\/logo-landscape-800x281-800x281-1.png","contentUrl":"https:\/\/genekor.com\/wp-content\/uploads\/2025\/01\/logo-landscape-800x281-800x281-1.png","width":800,"height":281},{"@type":"BreadcrumbList","@id":"https:\/\/genekor.com\/ro\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/genekor.com\/ro\/"},{"@type":"ListItem","position":2,"name":"Teste de profil tumoral pentru ghidarea deciziilor privind chimioterapia adjuvant\u0103 \u00een cancerul de s\u00e2n incipient"}]},{"@type":"WebSite","@id":"https:\/\/genekor.com\/ro\/#website","url":"https:\/\/genekor.com\/ro\/","name":"Genekor","description":"Medicina personalizat\u0103","publisher":{"@id":"https:\/\/genekor.com\/ro\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/genekor.com\/ro\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ro-RO"},{"@type":"Organization","@id":"https:\/\/genekor.com\/ro\/#organization","name":"Genekor","url":"https:\/\/genekor.com\/ro\/","logo":{"@type":"ImageObject","inLanguage":"ro-RO","@id":"https:\/\/genekor.com\/ro\/#\/schema\/logo\/image\/","url":"https:\/\/genekor.com\/wp-content\/uploads\/2021\/09\/logo-black.svg","contentUrl":"https:\/\/genekor.com\/wp-content\/uploads\/2021\/09\/logo-black.svg","width":1,"height":1,"caption":"Genekor"},"image":{"@id":"https:\/\/genekor.com\/ro\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/genekorbiotechnology\/","https:\/\/gr.linkedin.com\/company\/genekor-sa","https:\/\/www.youtube.com\/channel\/UCKC7sMFecVBY-OZAlRBHNzA"]},{"@type":"Person","@id":"https:\/\/genekor.com\/ro\/#\/schema\/person\/d6c43cd4b4be66582d408967392cbcbd","name":"Ioanna Potska","image":{"@type":"ImageObject","inLanguage":"ro-RO","@id":"https:\/\/genekor.com\/ro\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ef44ac80c13d1335f0ea78257146bbf1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ef44ac80c13d1335f0ea78257146bbf1?s=96&d=mm&r=g","caption":"Ioanna Potska"}}]}},"_links":{"self":[{"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/posts\/15023","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/comments?post=15023"}],"version-history":[{"count":2,"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/posts\/15023\/revisions"}],"predecessor-version":[{"id":15026,"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/posts\/15023\/revisions\/15026"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/media\/15021"}],"wp:attachment":[{"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/media?parent=15023"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/categories?post=15023"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/tags?post=15023"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}